The synthesis of 19-nor-1α, 25-dihydroxy-22-oxo-vitamin D3

被引：0
|
作者：
Wu, Y
Guan, M
Li, PJ
Xu, C
Wu, XC
机构：
[1] W China Univ Med Sci, Sch Pharm, Chengdu 610041, Peoples R China
[2] W China Univ Med Sci, Hosp 1, Chengdu 610041, Peoples R China
来源：
CHINESE CHEMICAL LETTERS | 2001年 / 12卷 / 01期
关键词：
19-nor-1; alpha; 25-dihydroxy-22-oxo-vitamin D-3; device; synthesis;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
19-Nor-1 alpha, 25-dihydroxy-22-oxo-vitamin D-3 4 was synthesized by the coupling of known compound 5 and the A-ring phosphine oxide 6 followed by deprotection of the hydroxy functions.
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [21] The classic receptor for 1α,25-dihydroxy vitamin D3 is required for non-genomic actions of 1α,25-dihydroxy vitamin D3 in osteosarcoma cells
    Bravo, Soraya
    Paredes, Roberto
    Izaurieta, Pamela
    Lian, Jane B.
    Stein, Janet L.
    Stein, Gary S.
    Hinrichs, Maria Victoria
    Olate, Juan
    Aguayo, Luis G.
    Montecino, Martin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (04) : 995 - 1000
  • [22] Recent Developments of 19-Nor-1,25-dihydroxyvitamin D3 Analogues
    Zhang, Can-Fei
    Wan, Ren-Zhong
    Liu, Zhao-Peng
    CHEMMEDCHEM, 2013, 8 (08) : 1249 - 1260
  • [23] Synthesis of 2-methyl and ethyl-substituted 19-nor-1α,25-dihydroxyvitamin D3 analogues via the cyclovitamin strategy
    Zhao, YR
    Guang, B
    Bouillon, R
    Verstuyf, A
    De Clercq, P
    Vandewalle, M
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2005, 2005 (20) : 4414 - 4427
  • [24] Synthesis of Diastereomers of 1,3-cis-25-Dihydroxy-19-norvitamin D3
    Usuda, Kosuke
    Biswas, Tanima
    Yamaguchi, Takuya
    Akagi, Yusuke
    Yasui, Koji
    Uesugi, Motonari
    Shimizu, Isao
    Hosokawa, Seijiro
    Nagasawa, Kazuo
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2016, 64 (08) : 1190 - 1195
  • [25] Synthesis of novel 1α,25-dihydroxy-19-norvitamin D3 with an amide conjugate
    Suhara, Y
    Ono, K
    Yoshida, A
    Fujishima, T
    Saito, N
    Honzawa, S
    Kishimoto, S
    Sugiura, T
    Waku, K
    Takayama, H
    Kittaka, A
    HETEROCYCLES, 2004, 62 : 423 - 436
  • [26] The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1α,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer
    Chen, TC
    Schwartz, GG
    Burnstein, KL
    Lokeshwar, BL
    Holick, MF
    CLINICAL CANCER RESEARCH, 2000, 6 (03) : 901 - 908
  • [27] 1α,25-dihydroxy-3-epi-vitamin D3:: In vivo metabolite of 1α,25-dihydroxyvitamin D3 in rats
    Sekimoto, H
    Siu-Caldera, ML
    Weiskopf, A
    Vouros, P
    Muralidharan, KR
    Okamura, WH
    Uskokovic, MR
    Reddy, GS
    FEBS LETTERS, 1999, 448 (2-3) : 278 - 282
  • [28] (10Z)- and (10E)-19-fluoro-1α,25-dihydroxyvitamin D3:: An improved synthesis via 19-nor-10-oxo-vitamin D
    Shimizu, M
    Ohno, A
    Yamada, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (03) : 312 - 317
  • [29] Synthesis of the enantiomer of 1α,25-dihydroxy vitamin D3 (calcitriol) and a diastereomer of 1α,25-dihydroxy vitamin D3 differing from natural product in configuration at all but one asymmetric carbon atoms
    Achmatowicz, B
    Przezdziecka, A
    Wicha, J
    POLISH JOURNAL OF CHEMISTRY, 2005, 79 (02) : 413 - 428
  • [30] BIOLOGIC ACTION OF 1,25 DIHYDROXY-VITAMIN D3 AND 1ALPHA-HYDROXY-VITAMIN-D3 D3 IN MAN
    FRIEDMAN, GS
    BRICKMAN, AS
    COBURN, JW
    MITRA, MN
    OKAMURA, WH
    NORMAN, AW
    FEDERATION PROCEEDINGS, 1975, 34 (03) : 894 - 894
12345